PubRank

Carol F Lippa

Author PubWeight™ 33.20‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Amyloid deposition begins in the striatum of presenilin-1 mutation carriers from two unrelated pedigrees. J Neurosci 2007 3.91
2 LR11/SorLA expression is reduced in sporadic Alzheimer disease but not in familial Alzheimer disease. J Neuropathol Exp Neurol 2006 1.72
3 Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimer's diseases. Hum Mol Genet 2012 1.46
4 Neuronal RNA oxidation is a prominent feature of familial Alzheimer's disease. Neurobiol Dis 2004 1.13
5 Dementia with Lewy bodies and Parkinson's disease dementia may best be viewed as two distinct entities. Int Psychogeriatr 2009 1.13
6 Hippocampal sclerosis dementia: expanding the phenotypes of frontotemporal dementias? Neurology 2004 1.05
7 Disruption of glutamate receptors at Shank-postsynaptic platform in Alzheimer's disease. Brain Res 2009 1.04
8 Lewy body dementia: caregiver burden and unmet needs. Alzheimer Dis Assoc Disord 2010 1.03
9 Selective reduction of soluble tau proteins in sporadic and familial frontotemporal dementias: an international follow-up study. Acta Neuropathol 2003 1.00
10 Lewy body dementia: the caregiver experience of clinical care. Parkinsonism Relat Disord 2010 0.98
11 Lewy bodies in the amygdala: increase of alpha-synuclein aggregates in neurodegenerative diseases with tau-based inclusions. Arch Neurol 2004 0.98
12 Review: disruption of the postsynaptic density in Alzheimer's disease and other neurodegenerative dementias. Am J Alzheimers Dis Other Demen 2010 0.95
13 Caffeine: neuroprotective functions in cognition and Alzheimer's disease. Am J Alzheimers Dis Other Demen 2009 0.92
14 The influence of beta-blockers on delayed memory function in people with cognitive impairment. Am J Alzheimers Dis Other Demen 2007 0.91
15 Lewy body dementia. Int Rev Neurobiol 2009 0.89
16 Notch-1 immunoexpression is increased in Alzheimer's and Pick's disease. J Neurol Sci 2006 0.86
17 A clinical approach to early-onset inheritable dementia. Am J Alzheimers Dis Other Demen 2012 0.86
18 Alzheimer's disease and other dementias: a review. Am J Alzheimers Dis Other Demen 2002 0.86
19 Alpha-Synuclein aggregation in pathological aging and Alzheimer's disease: the impact of beta-amyloid plaque level. Am J Alzheimers Dis Other Demen 2005 0.85
20 Cognition and amyotrophic lateral sclerosis (ALS). Am J Alzheimers Dis Other Demen 2007 0.83
21 Progranulin and beta-amyloid distribution: a case report of the brain from preclinical PS-1 mutation carrier. Am J Alzheimers Dis Other Demen 2009 0.82
22 Alzheimer neuropathology in nondemented aging: keeping mind over matter. Neurology 2006 0.80
23 Neuritic pathology as a correlate of synaptic loss in dementia with lewy bodies. Am J Alzheimers Dis Other Demen 2008 0.80
24 Presenilin-1 C410Y Alzheimer disease plaques contain synaptic proteins. Am J Alzheimers Dis Other Demen 2007 0.80
25 Dementia with Lewy bodies: improving diagnostic criteria. Neurology 2003 0.79
26 Dementia: many roads, but not built in a day. Neurology 2007 0.78
27 Effects of prescribed medications on cognition and behavior in frontotemporal lobar degeneration. Am J Alzheimers Dis Other Demen 2010 0.77
28 Cerebrospinal immunoglobulin level changes and clinical response to treatment of Hashimoto's encephalopathy. Am J Alzheimers Dis Other Demen 2009 0.76
29 Association between progranulin and beta-amyloid in dementia with Lewy bodies. Am J Alzheimers Dis Other Demen 2009 0.76
30 Compensating for Alzheimer lesions: evidence that size counts. Neurology 2009 0.75
31 Characterizing clinical phenotypes: the Lewys in their life or the life of their Lewys? Neurology 2006 0.75
32 Tarot decks and PET scans: predicting the future of MCI. Neurology 2010 0.75
33 Uplifting news for frontotemporal dementia: The sagging brain syndrome. Neurology 2011 0.75
34 Review of issue: the impact of time of day, mood, and caregiver stress on function in patients with dementia. Am J Alzheimers Dis Other Demen 2010 0.75
35 Safety, end-of-life issues, and dealing with sexually inappropriate behavior in dementia patients. Am J Alzheimers Dis Other Demen 2008 0.75
36 Strategies for patient diagnosis and management. Am J Alzheimers Dis Other Demen 2009 0.75
37 Interventions and diagnostics in Alzheimer's disease and related conditions. Am J Alzheimers Dis Other Demen 2010 0.75
38 Primary progressive aphasia and caregiver issues. Am J Alzheimers Dis Other Demen 2009 0.75
39 Review of issue: caregiver depression and a plan to manage resistance to care. Am J Alzheimers Dis Other Demen 2011 0.75
40 The media and cognitive health in our aging population. Am J Alzheimers Dis Other Demen 2009 0.75
41 Focusing on the caregiver: grief in dementia caregiving. Am J Alzheimers Dis Other Demen 2010 0.75
42 Review of issue: studies on veterans, a useful pain scale, and plasma amyloid levels as a predictor of response to medications. Am J Alzheimers Dis Other Demen 2008 0.75
43 Review of issue: changing environment and activities for the patients with dementia: what can we do to ease the burden? Am J Alzheimers Dis Other Demen 2010 0.75
44 The corpus callosum in Pick's disease, Alzheimer's disease, and amyotrophic lateral sclerosis: gliosis implies possible clinical consequence. Am J Alzheimers Dis Other Demen 2006 0.75
45 Genetic aspects of Alzheimer's disease, Pick's disease, and other dementias. Am J Alzheimers Dis Other Demen 2004 0.75
46 Caffeine, ethical and practical challenges, and nonpharmaceutical interventions for Alzheimer's and related dementias. Am J Alzheimers Dis Other Demen 2009 0.75
47 Clinical characterization in Alzheimer disease. Am J Alzheimers Dis Other Demen 2009 0.75
48 Barriers to hospice in patients with Alzheimer. Am J Alzheimers Dis Other Demen 2009 0.75